Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer

The Long Run with Luke Timmerman - En podcast av Timmerman Report

Podcast artwork

Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.

Visit the podcast's native language site